Published in Gene Ther on August 01, 1999
A crucial role for RACK1 in the regulation of glucose-stimulated IRE1alpha activation in pancreatic beta cells. Sci Signal (2010) 1.52
Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys J (2003) 1.50
Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng (2005) 1.50
Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells. Small (2010) 1.23
Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J Biomed Mater Res A (2006) 1.20
The adaptor function of TRAPPC2 in mammalian TRAPPs explains TRAPPC2-associated SEDT and TRAPPC9-associated congenital intellectual disability. PLoS One (2011) 1.13
The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor. Biomaterials (2013) 1.10
Enhanced gene delivery using disulfide-crosslinked low molecular weight polyethylenimine with listeriolysin o-polyethylenimine disulfide conjugate. J Control Release (2008) 0.97
Combinatorial evaluation of cations, pH-sensitive and hydrophobic moieties for polymeric vector design. Mol Ther (2009) 0.94
Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors. Mol Pharm (2008) 0.94
Sequential activation of Snail1 and N-Myc modulates sonic hedgehog-induced transformation of neural cells. Cancer Res (2011) 0.92
Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother (2009) 0.91
Thermodynamics of polyethylenimine-DNA binding and DNA condensation. Biophys J (2010) 0.89
Serum-free transfection of CHO cells with chemically defined transfection systems and investigation of their potential for transient and stable transfection. Cytotechnology (2009) 0.88
Polyethyleneimine mediated DNA transfection in schistosome parasites and regulation of the WNT signaling pathway by a dominant-negative SmMef2. PLoS Negl Trop Dis (2013) 0.87
Silica nanoparticles as a delivery system for nucleic acid-based reagents. J Mater Chem (2009) 0.85
Characterization and evaluation of the efficacy of cationic complex mediated plasmid DNA delivery in human embryonic palatal mesenchyme cells. J Tissue Eng Regen Med (2014) 0.83
Condensation of oligonucleotides assembled into nicked and gapped duplexes: potential structures for oligonucleotide delivery. Nucleic Acids Res (2005) 0.83
2007 AIChE Alpha Chi Sigma Award: From Material to Tissue: Biomaterial Development, Scaffold Fabrication, and Tissue Engineering. AIChE J (2008) 0.82
MicroRNA-223 Induced Repolarization of Peritoneal Macrophages Using CD44 Targeting Hyaluronic Acid Nanoparticles for Anti-Inflammatory Effects. PLoS One (2016) 0.80
Effect of pendant group on pDNA delivery by cationic-β-cyclodextrin:alkyl-PVA-PEG pendant polymer complexes. Biomacromolecules (2013) 0.79
Effect of pore structure of macroporous poly(lactide-co-glycolide) scaffolds on the in vivo enrichment of dendritic cells. ACS Appl Mater Interfaces (2014) 0.78
The non-catalytic carboxyl-terminal domain of ARFGAP1 regulates actin cytoskeleton reorganization by antagonizing the activation of Rac1. PLoS One (2011) 0.78
A role for protein inhibitor of activated STAT1 (PIAS1) in lipogenic regulation through SUMOylation-independent suppression of liver X receptors. J Biol Chem (2012) 0.78
Polyplex Evolution: Understanding Biology, Optimizing Performance. Mol Ther (2017) 0.76
Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex. J Control Release (2012) 0.76
High-throughput screening of clinically approved drugs that prime polyethylenimine transfection reveals modulation of mitochondria dysfunction response improves gene transfer efficiencies. Bioeng Transl Med (2016) 0.75
Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice. J Vet Sci (2011) 0.75
Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators. N Engl J Med (1993) 5.14
Poly(ethylenimine) and its role in gene delivery. J Control Release (1999) 3.78
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation (1997) 3.27
Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost (1993) 3.12
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci U S A (1999) 2.81
Review: tissue engineering for regeneration of articular cartilage. Biomaterials (2000) 2.40
Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res (1999) 2.33
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2001) 2.32
A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet (1974) 2.29
Detailed alignment of saccharum and sorghum chromosomes: comparative organization of closely related diploid and polyploid genomes. Genetics (1998) 2.24
Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. J Biomed Mater Res (1997) 2.21
Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation (1999) 2.08
Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials (2001) 1.94
Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res (1993) 1.88
ARIC hemostasis study--I. Development of a blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost (1989) 1.86
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials (1996) 1.76
Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials (2000) 1.73
Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol (2001) 1.73
Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials (1998) 1.69
Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterials (2001) 1.65
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate. Proc Natl Acad Sci U S A (1999) 1.60
Water immersion versus standard colonoscopy insertion technique: randomized trial shows promise for minimal sedation. Endoscopy (2010) 1.56
Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res (2000) 1.50
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis. Circulation (1999) 1.49
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet (1981) 1.49
State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation (2001) 1.47
Characterization of the genomic structure, chromosomal location and promoter of human prostaglandin H synthase-2 gene. Biochem Biophys Res Commun (1994) 1.44
Growth factor delivery for tissue engineering. Pharm Res (2000) 1.42
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis (1991) 1.40
Biomaterials and bone mechanotransduction. Biomaterials (2001) 1.39
Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. Biomaterials (1998) 1.30
In vitro degradation of thin poly(DL-lactic-co-glycolic acid) films. J Biomed Mater Res (1999) 1.30
Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules (2001) 1.26
Polymer concepts in tissue engineering. J Biomed Mater Res (1998) 1.25
Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer. Clin Cancer Res (2001) 1.25
Growth factor-loaded scaffolds for bone engineering. J Control Release (2005) 1.25
In vitro degradation of a poly(propylene fumarate)-based composite material. Biomaterials (1996) 1.24
Synthesis and properties of photocross-linked poly(propylene fumarate) scaffolds. J Biomater Sci Polym Ed (2001) 1.24
Metastatic tumors of the hand: a report of six cases. J Hand Surg Am (1978) 1.24
Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage (2006) 1.24
Review: Hydrogels for cell immobilization. Biotechnol Bioeng (1996) 1.21
Endothelium-dependent contractions are associated with both augmented expression of prostaglandin H synthase-1 and hypersensitivity to prostaglandin H2 in the SHR aorta. Circ Res (1995) 1.20
Increased platelet aggregates in patients with transient ischemic attacks. Stroke (1975) 1.20
Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and L-ascorbic acid. J Cell Biochem (1998) 1.19
Pore morphology effects on the fibrovascular tissue growth in porous polymer substrates. Cell Transplant (1994) 1.17
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care (1999) 1.16
Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials (1998) 1.16
Aspirin and salicylate: An old remedy with a new twist. Circulation (2000) 1.15
Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release (2005) 1.14
Fallibility of the clinical diagnosis of venous thrombosis. JAMA (1975) 1.14
The importance of new processing techniques in tissue engineering. MRS Bull (1996) 1.14
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J Mater Sci Mater Med (2006) 1.12
In vivo degradation of a poly(propylene fumarate)/beta-tricalcium phosphate injectable composite scaffold. J Biomed Mater Res (1998) 1.12
Biological activity of rhBMP-2 released from PLGA microspheres. J Biomech Eng (2000) 1.12
Colocalization and interaction of cyclooxygenase-2 with caveolin-1 in human fibroblasts. J Biol Chem (2001) 1.12
Marrow stromal osteoblast function on a poly(propylene fumarate)/beta-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials (2000) 1.11
The ingrowth of new bone tissue and initial mechanical properties of a degrading polymeric composite scaffold. Tissue Eng (1995) 1.11
Growing new organs. Sci Am (1999) 1.10
Cysteine 99 of endothelial nitric oxide synthase (NOS-III) is critical for tetrahydrobiopterin-dependent NOS-III stability and activity. Biochem Biophys Res Commun (1995) 1.10
In vivo evaluation of poly(L-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials (1999) 1.10
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb (1993) 1.08
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Arterioscler Thromb (1993) 1.08
Crosslinking characteristics of an injectable poly(propylene fumarate)/beta-tricalcium phosphate paste and mechanical properties of the crosslinked composite for use as a biodegradable bone cement. J Biomed Mater Res (1999) 1.07
Fabrication of biodegradable polymer scaffolds to engineer trabecular bone. J Biomater Sci Polym Ed (1995) 1.07
Spontaneous platelet aggregation in arterial insufficiency: mechanisms and implications. Thromb Haemost (1976) 1.06
Cysteine 184 of endothelial nitric oxide synthase is involved in heme coordination and catalytic activity. J Biol Chem (1994) 1.06
Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym Ed (2006) 1.06
Smoking cessation among Hong Kong Chinese smokers attending hospital as outpatients: impact of doctors' advice, successful quitting and intention to quit. Asia Pac J Public Health (2004) 1.06
Bone tissue engineering. Nat Med (1995) 1.05
Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation (1995) 1.05
Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. Biomaterials (2000) 1.05
In vitro growth factor release from injectable calcium phosphate cements containing gelatin microspheres. J Biomed Mater Res A (2009) 1.05
Guided tissue fabrication from periosteum using preformed biodegradable polymer scaffolds. Biomaterials (1999) 1.05
In vitro cytotoxicity and in vivo biocompatibility of poly(propylene fumarate-co-ethylene glycol) hydrogels. J Biomed Mater Res (1999) 1.04
Platelet adhesion on a bioresorbable poly(propylene fumarate-co-ethylene glycol) copolymer. Biomaterials (1999) 1.03
Influence of natural and recombinant interleukin 2 on endothelial cell arachidonate metabolism. Induction of de novo synthesis of prostaglandin H synthase. J Clin Invest (1988) 1.03
Metastatic tumors of the foot. South Med J (1978) 1.02
Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells. J Biol Chem (2000) 1.01
Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger. J Biomater Sci Polym Ed (1999) 1.01
Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med (1978) 1.00
Osteoblast function on synthetic biodegradable polymers. J Biomed Mater Res (1994) 1.00
Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem (1996) 1.00
Up-regulation of endothelial nitric-oxide synthase promoter by the phosphatidylinositol 3-kinase gamma /Janus kinase 2/MEK-1-dependent pathway. J Biol Chem (2001) 1.00
Recent progress in gene delivery using non-viral transfer complexes. J Control Release (2001) 1.00
Mechanical properties of a biodegradable bone regeneration scaffold. J Biomech Eng (2000) 0.99
Fabrication of pliable biodegradable polymer foams to engineer soft tissues. Cell Transplant (1997) 0.99
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost (1994) 0.98
In vitro degradation of porous poly(L-lactic acid) foams. Biomaterials (2000) 0.98
Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res (2000) 0.97
Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem (1995) 0.97
TGF-beta1 release from biodegradable polymer microparticles: its effects on marrow stromal osteoblast function. J Bone Joint Surg Am (2001) 0.97
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery. J Biomed Mater Res (1997) 0.97
Characterization of the roles of the 594-645 region in human endothelial nitric-oxide synthase in regulating calmodulin binding and electron transfer. J Biol Chem (2000) 0.96